Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Rossari Biotech Limited (NSE: ROSSARI), ISIN INE02A801020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ROSSARI last traded at ₹454.80 (+2.84%), with a 52-week range of ₹372.90 to ₹690.90 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 68.14%, FIIs 2.02%, DIIs 14.64%, mutual funds 9.77%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.